학술논문

Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAR 1 2022, 40 7, 13p.
Subject
Language
English
ISSN
15277755